Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Increase (Decrease) in Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

Co-Diagnostics, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities

Co-Diagnostics, Inc. (CODX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$765.96 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-13

  • Co-Diagnostics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$1.41M.
  • Co-Diagnostics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $639.08K.
  • Co-Diagnostics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $80.47K, a 95.70% decline year-over-year.
  • Co-Diagnostics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $19.73K, a 96.75% decline year-over-year.
  • Co-Diagnostics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$3.11M, a 244.26% decline from fiscal 2024.
  • Co-Diagnostics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $2.16M, a 22.03% increase from fiscal 2023.
  • Co-Diagnostics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $1.77M.
  • Co-Diagnostics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$2.48M.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filedIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month
2026-06-30-$1.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$765.96K
10-Q · filed 2026-08-13
-$685.49K
derived: sum of 3 quarters · filed 2026-08-13
-$665.76K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$639.08K
10-Q · filed 2026-05-14
$719.55K
derived: sum of 2 quarters · filed 2026-05-14
$739.28K
derived: sum of 3 quarters · filed 2026-05-14
-$919.87K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$80.47K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$100.20K
derived: sum of 2 quarters · filed 2026-03-31
-$1.56M
derived: sum of 3 quarters · filed 2026-08-13
-$3.11M
10-K · filed 2026-03-31
2025-09-30$19.73K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$1.64M
derived: sum of 2 quarters · filed 2026-08-13
-$3.19M
10-Q · filed 2025-11-13
-$1.32M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$1.66M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$3.21M
10-Q · filed 2026-08-13
-$1.34M
derived: sum of 3 quarters · filed 2026-08-13
-$736.52K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$1.55M
10-Q · filed 2026-05-14
$315.39K
derived: sum of 2 quarters · filed 2026-05-14
$922.63K
derived: sum of 3 quarters · filed 2026-05-14
$906.58K
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$1.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$2.48M
derived: sum of 2 quarters · filed 2026-03-31
$2.46M
derived: sum of 3 quarters · filed 2026-03-31
$2.16M
10-K · filed 2026-03-31
2024-09-30$607.24K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$591.19K
derived: sum of 2 quarters · filed 2025-11-13
$288.51K
10-Q · filed 2025-11-13
$700.51K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$16.05K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$318.73K
10-Q · filed 2025-08-14
$93.27K
derived: sum of 3 quarters · filed 2025-08-14
-$4.63K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$302.68K
10-Q · filed 2025-05-08
$109.31K
derived: sum of 2 quarters · filed 2025-05-08
$11.42K
derived: sum of 3 quarters · filed 2025-05-08
$1.03M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$412.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$314.10K
derived: sum of 2 quarters · filed 2025-03-27
$1.33M
derived: sum of 3 quarters · filed 2025-03-27
$1.77M
10-K · filed 2025-03-27
2023-09-30-$97.90K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$920.64K
derived: sum of 2 quarters · filed 2024-11-07
$1.36M
10-Q · filed 2024-11-07
-$324.54K
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$1.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$1.45M
10-Q · filed 2024-08-08
$1.45M
10-Q · filed 2023-08-10
-$226.64K
derived: sum of 3 quarters · filed 2024-08-08
$673.12K
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$435.69K
10-Q · filed 2024-05-09
-$1.25M
derived: sum of 2 quarters · filed 2024-05-09
-$345.42K
derived: sum of 3 quarters · filed 2024-05-09
-$1.41M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$1.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
-$781.10K
derived: sum of 2 quarters · filed 2024-03-14
-$1.84M
derived: sum of 3 quarters · filed 2024-03-14
-$2.48M
10-K · filed 2024-03-14
2022-09-30$899.76K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$161.35K
derived: sum of 2 quarters · filed 2023-11-09
-$802.96K
10-Q · filed 2023-11-09
-$1.19M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$1.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$1.70M
10-Q · filed 2023-08-10
-$2.09M
derived: sum of 3 quarters · filed 2023-08-10
-$3.72M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$641.60K
10-Q · filed 2023-05-11
-$1.02M
derived: sum of 2 quarters · filed 2023-05-11
-$2.66M
derived: sum of 3 quarters · filed 2023-05-11
-$280.43K
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$382.43K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
-$2.02M
derived: sum of 2 quarters · filed 2023-03-16
$361.18K
derived: sum of 3 quarters · filed 2023-03-16
-$299.94K
10-K · filed 2023-03-16
2021-09-30-$1.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$743.61K
derived: sum of 2 quarters · filed 2022-11-10
$82.50K
10-Q · filed 2022-11-10
$3.18M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$2.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$1.72M
10-Q · filed 2022-08-11
$4.82M
derived: sum of 3 quarters · filed 2022-08-11
$3.93M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$661.12K
10-Q · filed 2022-05-12
$2.44M
derived: sum of 2 quarters · filed 2022-05-12
$1.56M
derived: sum of 3 quarters · filed 2022-05-12
$2.71M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$3.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
$2.22M
derived: sum of 2 quarters · filed 2022-03-24
$3.37M
derived: sum of 3 quarters · filed 2022-03-24
$3.76M
10-K · filed 2022-03-24
2020-09-30-$885.75K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$264.31K
derived: sum of 2 quarters · filed 2021-11-12
$656.60K
10-Q · filed 2021-11-12
$659.85K
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
$1.54M
10-Q · filed 2021-08-12
$1.55M
derived: sum of 3 quarters · filed 2021-08-12
$1.51M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$392.29K
10-Q · filed 2021-05-13
$395.54K
derived: sum of 2 quarters · filed 2021-05-13
$356.96K
derived: sum of 3 quarters · filed 2021-05-13
$311.53K
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$3.25K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
-$35.33K
derived: sum of 2 quarters · filed 2021-03-25
-$80.76K
derived: sum of 3 quarters · filed 2021-03-25
-$226.66K
10-K · filed 2021-03-25
2019-09-30-$38.58K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16
-$84.01K
derived: sum of 2 quarters · filed 2020-11-16
-$229.91K
10-Q · filed 2020-11-16
-$77.66K
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30-$45.43K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03
-$191.33K
10-Q/A · filed 2020-11-03
-$39.08K
derived: sum of 3 quarters · filed 2020-11-03
-$39.30K
derived: sum of 4 quarters · filed 2020-11-03
2019-03-31-$145.90K
10-Q · filed 2020-05-14
$6.35K
derived: sum of 2 quarters · filed 2020-05-14
$6.13K
derived: sum of 3 quarters · filed 2020-05-14
-$19.64K
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$152.25K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$152.03K
derived: sum of 2 quarters · filed 2020-03-30
$126.26K
derived: sum of 3 quarters · filed 2020-03-30
$85.95K
10-K · filed 2020-03-30
2018-09-30-$225.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$26.00K
derived: sum of 2 quarters · filed 2019-11-12
-$66.31K
10-Q · filed 2019-11-12
-$115.07K
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$25.77K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$66.08K
10-Q · filed 2019-08-14
-$114.84K
derived: sum of 3 quarters · filed 2019-08-14
-$388.35K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31-$40.31K
10-Q · filed 2019-05-14
-$89.07K
derived: sum of 2 quarters · filed 2019-05-14
-$362.58K
derived: sum of 3 quarters · filed 2019-05-14
-$221.78K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31-$48.76K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$322.27K
derived: sum of 2 quarters · filed 2019-04-01
-$181.48K
derived: sum of 3 quarters · filed 2019-04-01
$8.37K
10-K · filed 2019-04-01
2017-09-30-$273.51K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
-$132.71K
derived: sum of 2 quarters · filed 2018-11-14
$57.13K
10-Q · filed 2018-11-14
2017-06-30$140.79K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
$330.64K
10-Q · filed 2018-08-10
2017-03-31$189.85K
10-Q · filed 2018-05-14
2016-09-30$107.99K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$461.65K
10-Q · filed 2017-11-14
2016-06-30$353.67K
10-Q · filed 2017-08-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01